HomeCompareOCDX vs NNN

OCDX vs NNN: Dividend Comparison 2026

OCDX yields 11.34% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCDX wins by $16.7K in total portfolio value
10 years
OCDX
OCDX
● Live price
11.34%
Share price
$17.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.3K
Annual income
$2,306.36
Full OCDX calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — OCDX vs NNN

📍 OCDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCDXNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCDX + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCDX pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCDX
Annual income on $10K today (after 15% tax)
$964.27/yr
After 10yr DRIP, annual income (after tax)
$1,960.41/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, NNN beats the other by $281.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCDX + NNN for your $10,000?

OCDX: 50%NNN: 50%
100% NNN50/50100% OCDX
Portfolio after 10yr
$33.9K
Annual income
$2,471.89/yr
Blended yield
7.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

OCDX
No analyst data
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCDX buys
0
NNN buys
0
No recent congressional trades found for OCDX or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCDXNNN
Forward yield11.34%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$42.3K$25.6K
Annual income after 10y$2,306.36$2,637.42
Total dividends collected$17.1K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: OCDX vs NNN ($10,000, DRIP)

YearOCDX PortfolioOCDX Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$11,834$1,134.43$10,737$617.02+$1.1KOCDX
2$13,918$1,254.70$11,577$710.93+$2.3KOCDX
3$16,271$1,379.03$12,538$822.59+$3.7KOCDX
4$18,916$1,506.73$13,645$956.06+$5.3KOCDX
5$21,878$1,637.13$14,925$1,116.51+$7.0KOCDX
6$25,179$1,769.55$16,415$1,310.57+$8.8KOCDX
7$28,845$1,903.31$18,158$1,546.77+$10.7KOCDX
8$32,901$2,037.77$20,213$1,836.20+$12.7KOCDX
9$37,377$2,172.31$22,649$2,193.37+$14.7KOCDX
10$42,300$2,306.36$25,558$2,637.42+$16.7KOCDX

OCDX vs NNN: Complete Analysis 2026

OCDXStock

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Full OCDX Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this OCDX vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCDX vs SCHDOCDX vs JEPIOCDX vs OOCDX vs KOOCDX vs MAINOCDX vs ADCOCDX vs EPRTOCDX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.